Drug intelligence / Profile preview

sigesbeckia orientalis extract

Development stage
Unknown
Lead developer
Phynova
Administration
Oral
01

Overview

Phynova Joint and Muscle Relief Tablets is a traditional herbal medicinal product containing a dry water extract of the aerial parts of *Sigesbeckia orientalis* L. It was the first traditional Chinese medicine (TCM) to be approved as an over-the-counter (OTC) medicine by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under the Traditional Herbal Medicinal Product (THMP) Directive in February 2015. Developed through a collaboration between Phynova and Xiangxue Pharmaceutical, the product is indicated for the symptomatic relief of rheumatic or muscular pain, backache, and minor sports injuries. The active ingredient is prepared by Purapharm Pharmaceutical Co in China and manufactured into tablets by Surapharm Services Ltd in the UK. Its therapeutic effects are based on traditional use for anti-inflammatory and analgesic properties.

Brand names
Phynova Joint and Muscle Relief Tablets
Other names
Phynova Plant Drug (joint pain)Sigesbeckia orientalis extract

Beyond the preview

Go deeper on sigesbeckia orientalis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sigesbeckia orientalis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call